1.
Kanoun RY, Abdeljelil NB, Mekni S, Kasdallah M, Ouerghi R, Ben Yaiche I, et al. Role of measurable residual disease quantified by 4 to 6 color flow cytometry before allogeneic hematopoietic stem cell transplantation for high-risk Philadelphia-negative acute lymphoblastic leukemia. J Stem Cell Ther Transplant [Internet]. 2023 Apr. 14 [cited 2025 Apr. 25];7(1):016-23. Available from: https://www.stemcelltherjournal.com/jsctt/article/view/jsctt-aid1031